KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

RIFINAH 300 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

300 MG

 

GENERIC NAME:

RIFAMPICIN AND ISONIAZID

 

MANUFACTURER:

AVENTIS PHARMA

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Tuberculosis

 

SIDE EFFECTS:

Hepatitis

hepatitis prodromal symptoms

peripheral neuritis

"Flu-like" syndrome

hypersensitivity

Blood dyscrasias

interstitial nephritis

neurotoxicity

optic neuritis

Gastrointestinal disturbances

Fungal overgrowth

Reddish-orange to reddish-brown discoloration of urine, feces, saliva, sputum, sweat, and tears

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

>> Alcoholism, active or in remission

>> Hepatic function impairment, severe

>> Hypersensitivity to isoniazid, ethionamide, pyrazinamide, niacin , or other chemically related medications

Hypersensitivity to rifampin or rifabutin

Renal failure, severe

Seizure disorders

 

ADULT DOSE:

Tuberculosis- Oral, 600 mg of rifampin and 300 mg of isoniazid once a day for the entire treatment period .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Use of the fixed-dose combination is not recommended in pediatric patients. Note: See individual components for dosage recommendations.  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT